🔎 Trials Near Me

Beranda › Kanker (semua jenis) › Michigan › Grand Rapids

Uji klinis Kanker (semua jenis) di Grand Rapids, MI

28 studi untuk Kanker (semua jenis) mencari peserta di lokasi sekitar Grand Rapids (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)

Menerima pesertaFase 2
  • START Midwest ( Site 1103), Grand Rapids
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07209111

REC-7735 in Participants With Solid Tumors

Menerima pesertaFase 1/2
  • START Midwest, Grand Rapids
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT07819136

A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)

Menerima pesertaFase 1
  • START Midwest /ID# 279035, Grand Rapids
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT07409246

A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)

Menerima pesertaFase 1/2
  • Corewell Health ( Site 4001), Grand Rapids
1 Month – 17 Years · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07630974

A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms

Menerima pesertaFase 1
  • Start Midwest, Grand Rapids
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06150157

A Study of JNJ-87890387 for Advanced Solid Tumors

Menerima pesertaFase 1
  • Start Midwest, Grand Rapids
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06178614

A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

Menerima pesertaFase 3
  • Cancer And Hematology Centers Of Western Michigan - Grand Rapids /ID# 279955, Grand Rapids
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT07365241

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

Menerima pesertaFase 2
  • Cancer Research Consortium of West Michigan, Grand Rapids
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT02693535

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Menerima pesertaFase 1/2
  • START Midwest, Grand Rapids
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT06128551

A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)

Menerima pesertaFase 1/2
  • Corewell Health ( Site 3001), Grand Rapids
1 Month – 17 Years · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT06941272

A Phase 1/1b Study of IAM1363 in HER2 Cancers

Menerima pesertaFase 1
  • START - Midwest Cancer Research Center, Grand Rapids
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT06253871

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Menerima pesertaFase 3
  • The Cancer & Hematology Centers, Grand Rapids
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT06119581

Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation

Menerima pesertaFase 3
  • Cancer and Hematology Centers of Western Michigan, Grand Rapids
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT06252649

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer

Menerima pesertaFase 1
  • START Midwest, Grand Rapids
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 26 Agu 2026 · NCT07321106

Project: Every Child for Younger Patients With Cancer

Menerima pesertaStudi observasional
  • Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
  • Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
  • Trinity Health Grand Rapids Hospital, Grand Rapids
Hingga usia 25 · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT02402244

Two Part Study of Nenocorilant Combined With Nivolumab in Patients With Advanced Solid Malignancies

Menerima pesertaFase 1/2
  • Site 04, Grand Rapids
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 19 Agu 2026 · NCT07276373

A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies

Menerima pesertaFase 1
  • START Midwest, Grand Rapids
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 12 Agu 2026 · NCT06759649

A Study of mRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer Agents in Participants With Solid Tumors

Menerima pesertaFase 1
  • START Midwest, Grand Rapids
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Agu 2026 · NCT06880549

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Menerima pesertaFase 3
  • Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
  • Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 7 Agu 2026 · NCT06580314

A Study of [18F]LY4214835 in Healthy Volunteers and Participants With Cancer

Menerima pesertaFase 1Sukarelawan sehat diterima
  • BAMF Health Inc., Grand Rapids
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Agu 2026 · NCT07258836

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

Menerima pesertaFase 1/2
  • START Midwest, Grand Rapids
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 7 Jul 2026 · NCT05768139

A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)

Menerima pesertaFase 1
  • GSK Investigational Site, Grand Rapids
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Jun 2026 · NCT06431594

CT-95 in Advanced Cancers Associated With Mesothelin Expression

Menerima pesertaFase 1
  • Context Investigational Site, Grand Rapids
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 12 Jun 2026 · NCT06756035

A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

Menerima pesertaFase 1
  • START Midwest, Grand Rapids
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Mei 2026 · NCT07094204

A Study of YL242 in Subjects With Advanced Solid Tumors

Menerima pesertaFase 1/2
  • US-206, Grand Rapids
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Des 2025 · NCT07197827

A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product

Menerima pesertaStudi observasional
  • Corewell Health, Grand Rapids
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Jun 2025 · NCT05768269

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

Menerima peserta
  • Mercy Health Saint Mary's, Grand Rapids
  • Spectrum Health at Butterworth Campus, Grand Rapids
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 27 Nov 2024 · NCT03860883

Uji klinis Kanker (semua jenis) di kota lain

Studi lain di Grand Rapids

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.